| Fund Name | Location |
| Aon plc | England, London, United Kingdom |
| Cheng Tian Capital I | China, Hong Kong, Hong Kong Island |
| Chicago Venture Summit | Chicago, Illinois, United States |
| Commonwealth Research Commercialization Fund | - |
| Court Square Ventures | Charlottesville, United States, Virginia |
| CS Capital | China, Shanghai |
| Fusion LA | California, Santa Monica, United States |
| Hasso Plattner Institute | Brandenburg, Germany, Potsdam |
| IDF Capital SA | Gauteng, Johannesburg, South Africa |
| Kale United | Stockholm, Stockholm County, Sweden |
| Kwang Dong Pharmaceutical | Seocho, Seoul-t'ukpyolsi, South Korea |
| Leumi Partners | Israel, Tel Aviv, Tel Aviv District |
| MK Energy and Infrastructure | Connecticut, Stamford, United States |
| The Batchery Angels | - |
| TSK | Asturias, Gijón, Spain |
| View Worldwide Technology | China, Guangdong, Zhuhai |
| WDI GROUP | Japan, Tokyo |
| Weifang Hongtu Ziben | China, Japan, Kagoshima Prefecture |
| Wiel Brien Investments, LLC, | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shenzhen TargetRx | $2M | 24 Jul 2018 | Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shenzhen TargetRx | $2M | 24 Jul 2018 | Guangdong Province |
